These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 34838000)

  • 1. Bioinformatics prediction and experimental verification identify MAD2L1 and CCNB2 as diagnostic biomarkers of rhabdomyosarcoma.
    Xia T; Meng L; Zhao Z; Li Y; Wen H; Sun H; Zhang T; Wei J; Li F; Liu C
    Cancer Cell Int; 2021 Nov; 21(1):634. PubMed ID: 34838000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioinformatics Analysis and Validation Identify CDK1 and MAD2L1 as Prognostic Markers of Rhabdomyosarcoma.
    Lu S; Sun C; Chen H; Zhang C; Li W; Wu L; Zhu J; Sun F; Huang J; Wang J; Zhen Z; Cai R; Sun X; Zhang Y; Zhang X
    Cancer Manag Res; 2020; 12():12123-12136. PubMed ID: 33273853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CDK1 and CCNB1 as potential diagnostic markers of rhabdomyosarcoma: validation following bioinformatics analysis.
    Li Q; Zhang L; Jiang J; Zhang Y; Wang X; Zhang Q; Wang Y; Liu C; Li F
    BMC Med Genomics; 2019 Dec; 12(1):198. PubMed ID: 31870357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Multiple Hub Genes and Pathways in Hepatocellular Carcinoma: A Bioinformatics Analysis.
    Liu J; Han F; Ding J; Liang X; Liu J; Huang D; Zhang C
    Biomed Res Int; 2021; 2021():8849415. PubMed ID: 34337056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Screening core genes and cyclin B2 as a potential diagnosis, treatment and prognostic biomarker of hepatocellular carcinoma based on bioinformatics analysis].
    Yang SY; Ren H; Li CF; Tang H
    Zhonghua Gan Zang Bing Za Zhi; 2020 Sep; 28(9):773-783. PubMed ID: 33053978
    [No Abstract]   [Full Text] [Related]  

  • 6. Identification of Key Genes and Prognostic Value Analysis in Hepatocellular Carcinoma by Integrated Bioinformatics Analysis.
    Wang M; Wang L; Wu S; Zhou D; Wang X
    Int J Genomics; 2019; 2019():3518378. PubMed ID: 31886163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of tumour microenvironment-related genes by TCGA database in rectal cancer.
    Li C; Liu T; Liu Y; Zhang J; Zuo D
    J Cell Mol Med; 2021 Jun; 25(12):5811-5822. PubMed ID: 33949771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of prognostic biomarkers in papillary renal cell carcinoma and PTTG1 may serve as a biomarker for predicting immunotherapy response.
    Tian X; Xu WH; Xu FJ; Li H; Anwaier A; Wang HK; Wan FN; Zhu Y; Cao DL; Zhu YP; Shi GH; Qu YY; Zhang HL; Ye DW
    Ann Med; 2022 Dec; 54(1):211-226. PubMed ID: 35037540
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Meng L; He X; Hong Q; Qiao B; Zhang X; Wu B; Zhang X; Wei Y; Li J; Ye Z; Xiao Y
    Front Oncol; 2021; 11():618187. PubMed ID: 33692955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High Glycolytic Activity Signature Reveals CCNB2 as a Key Therapeutic Target in Triple-Negative Breast Cancer.
    Liang J; Ma H; Zhang S; Dong Y; Zheng J; Zeng L; Xiong X; Huang W; Yin Q; Zheng X
    Front Biosci (Landmark Ed); 2024 Aug; 29(8):308. PubMed ID: 39206892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MAD2L1 Functions As a Novel Diagnostic and Predictive Biomarker in Cholangiocarcinoma.
    Gao Y; Liu Y; Sun L; Ouyang X; Zhu C; Qin X
    Genet Test Mol Biomarkers; 2021 Nov; 25(11):685-695. PubMed ID: 34788140
    [No Abstract]   [Full Text] [Related]  

  • 12. Pathological significance of MAD2L1 in breast cancer: an immunohistochemical study and meta analysis.
    Zhu XF; Yi M; He J; Tang W; Lu MY; Li T; Feng ZB
    Int J Clin Exp Pathol; 2017; 10(9):9190-9201. PubMed ID: 31966791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioinformatic analysis revealing mitotic spindle assembly regulated NDC80 and MAD2L1 as prognostic biomarkers in non-small cell lung cancer development.
    Wei R; Wang Z; Zhang Y; Wang B; Shen N; E L; Li X; Shang L; Shang Y; Yan W; Zhang X; Ma W; Wang C
    BMC Med Genomics; 2020 Aug; 13(1):112. PubMed ID: 32795325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of hub genes and pathways in adrenocortical carcinoma by integrated bioinformatic analysis.
    Guo J; Gu Y; Ma X; Zhang L; Li H; Yan Z; Han Y; Xie L; Guo X
    J Cell Mol Med; 2020 Apr; 24(8):4428-4438. PubMed ID: 32147961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CCNB2, NUSAP1 and TK1 are associated with the prognosis and progression of hepatocellular carcinoma, as revealed by co-expression analysis.
    Liu L; Chen A; Chen S; Song W; Yao Q; Wang P; Zhou S
    Exp Ther Med; 2020 Apr; 19(4):2679-2689. PubMed ID: 32256749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening key genes and signaling pathways in colorectal cancer by integrated bioinformatics analysis.
    Yu C; Chen F; Jiang J; Zhang H; Zhou M
    Mol Med Rep; 2019 Aug; 20(2):1259-1269. PubMed ID: 31173250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of MAD2L1 and BUB1B as Potential Biomarkers Associated with Progression and Prognosis of Ovarian Cancer.
    Tang R; Tong J; Shang S; Li G; Sun F; Guan X; Yang J
    Biochem Genet; 2024 Apr; ():. PubMed ID: 38683465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MYL2 as a potential predictive biomarker for rhabdomyosarcoma.
    Wang J; Gao S; Dong K; Guo P; Shan MJ
    Medicine (Baltimore); 2021 Oct; 100(39):e27101. PubMed ID: 34596111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of prognostic biomarkers associated with stromal cell infiltration in muscle-invasive bladder cancer by bioinformatics analyses.
    Li P; Cao J; Li J; Yao Z; Han D; Ying L; Wang Z; Tian J
    Cancer Med; 2020 Oct; 9(19):7253-7267. PubMed ID: 32786144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening and Identification of Key Biomarkers in Inflammatory Breast Cancer Through Integrated Bioinformatic Analyses.
    Wu J; Lv Q; Huang H; Zhu M; Meng D
    Genet Test Mol Biomarkers; 2020 Aug; 24(8):484-491. PubMed ID: 32598242
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.